WO2003061538A1 - Pansements particulaires - Google Patents
Pansements particulaires Download PDFInfo
- Publication number
- WO2003061538A1 WO2003061538A1 PCT/GB2003/000197 GB0300197W WO03061538A1 WO 2003061538 A1 WO2003061538 A1 WO 2003061538A1 GB 0300197 W GB0300197 W GB 0300197W WO 03061538 A1 WO03061538 A1 WO 03061538A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- cellulose
- water
- particulate material
- dressing
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 claims abstract description 21
- 239000011236 particulate material Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 206010052428 Wound Diseases 0.000 claims description 69
- 208000027418 Wounds and injury Diseases 0.000 claims description 69
- 239000002245 particle Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 8
- 229940124597 therapeutic agent Drugs 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 230000029663 wound healing Effects 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 5
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 3
- -1 cetyl hydroxyl Chemical group 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 claims description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 239000000020 Nitrocellulose Substances 0.000 claims description 2
- 229920000153 Povidone-iodine Polymers 0.000 claims description 2
- 229940035676 analgesics Drugs 0.000 claims description 2
- 239000000730 antalgic agent Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 229960003260 chlorhexidine Drugs 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001220 nitrocellulos Polymers 0.000 claims description 2
- 229960001621 povidone-iodine Drugs 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 229960002900 methylcellulose Drugs 0.000 claims 1
- 229940079938 nitrocellulose Drugs 0.000 claims 1
- 229960000292 pectin Drugs 0.000 claims 1
- 239000012530 fluid Substances 0.000 abstract description 7
- 239000000499 gel Substances 0.000 description 16
- 239000000463 material Substances 0.000 description 14
- 210000000416 exudates and transudate Anatomy 0.000 description 7
- 230000002745 absorbent Effects 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00072—Packaging of dressings
- A61F13/00076—Packaging of adhesive dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0223—Adhesive bandages or dressings with fluid retention members characterized by parametric properties of the fluid retention layer, e.g. absorbency, wicking capacity, liquid distribution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
Definitions
- WO00/12144 describes particulate compositions capable of forming coherent, insoluble hydrogels in contact with wound fluid.
- the compositions are mixtures of two water soluble polymers that react in the presence of water to form an insoluble gel, for example a mixture of sodium carboxymethyl cellulose and chitosan.
- a further particulate composition of this type is COMFEEL (Registered Trade Mark) powder, supplied by Coloplast AS, which is a mixture of sodium carboxymethyl cellulose, guar gum and xanthan gum.
- Coloplast AS which is a mixture of sodium carboxymethyl cellulose, guar gum and xanthan gum.
- the powder is spread over the wound bed where it reacts with water to form an absorbent, insoluble gel.
- the insoluble gel on the wound bed is physically removed along with the secondary dressing covering the wound.
- the particulate materials are normally substantially free from water-insoluble components, or mixtures of components that react in solution to form insoluble gels, or support materials such as gauzes, films or foams that normally make up wound dressings.
- the particulate material is selected from the group consisting of sodium carboxymethyl cellulose, carboxymethyl cellulose, ethyl cellulose, hydroxyethyl cellulose, methylhydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyproplyethyl cellulose, cetyl hydroxyl cellulose, carboxymethyl hydroxethyl cellulose, methyl cellulose, carrageenan, pectin, nitrocellulose, soluble polyacrylates, guar gum derivatives, sodium alginate, and mixtures thereof.
- the particulate wound dressing according to the present invention is not a freeze-dried gel. That is to say, preferably the particulate wound dressing has not been made by freeze drying (lyophilizing) an aqueous solution or gel of the components.
- the material is sprinkled onto the exuding wound at a generally uniform thickness, typically about 0.5 to 5 mm thick, preferably 1 to 3 mm dry thickness, corresponding to a density of 0.02 to 0.2 are preferably 0.05 to 0.1g/cm 2 .
- the material absorbs the exudate to form a sticky gel layer that is flexible and breathable, and that swells and absorbs further exudate.
- the hydrogel layer completely covers the wound, but can be removed easily by washing with water or saline.
- a further advantage of this dressing is that, if exudate production exudes the capacity of the hydrogel, then instead of pooling under the hydrogel, the hydrogel layer simply dissolves and can be taken up in an absorbent secondary dressing over the hydrogel layer.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Medicinal Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0201385A GB2384187A (en) | 2002-01-22 | 2002-01-22 | Particulate wound dressing |
GB0201385.2 | 2002-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003061538A1 true WO2003061538A1 (fr) | 2003-07-31 |
Family
ID=9929508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2003/000197 WO2003061538A1 (fr) | 2002-01-22 | 2003-01-21 | Pansements particulaires |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2384187A (fr) |
WO (1) | WO2003061538A1 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696400B2 (en) | 2002-12-31 | 2010-04-13 | Ossur Hf | Wound dressing |
US7745682B2 (en) | 2003-09-17 | 2010-06-29 | Ossur Hf | Wound dressing and method for manufacturing the same |
US7939578B2 (en) | 2007-02-23 | 2011-05-10 | 3M Innovative Properties Company | Polymeric fibers and methods of making |
CN102218154A (zh) * | 2010-04-15 | 2011-10-19 | 郑明义 | 羧甲基羟乙基改性棉纤维止血织物及其制备方法 |
US8093445B2 (en) | 2003-09-17 | 2012-01-10 | Ossur Hf | Wound dressing and method for manufacturing the same |
CN105457080A (zh) * | 2015-12-09 | 2016-04-06 | 安徽宇宁生物科技有限公司 | 一种果胶创可贴 |
US9970303B2 (en) | 2014-05-13 | 2018-05-15 | Entrotech, Inc. | Erosion protection sleeve |
CN109833512A (zh) * | 2017-11-29 | 2019-06-04 | 江苏尚铖医疗器械有限公司 | 一种多功能创可贴 |
CN115382007A (zh) * | 2022-09-14 | 2022-11-25 | 安徽农业大学 | 一种抗菌和抗生物膜水凝胶及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391799A (en) * | 1980-02-15 | 1983-07-05 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for treating white phosphorus burn wounds |
US4393048A (en) * | 1980-02-15 | 1983-07-12 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for wounds |
US5902600A (en) * | 1992-12-21 | 1999-05-11 | Healthpoint, Ltd. | Hydrogel polymer wound dressing |
WO2000012144A1 (fr) * | 1998-08-31 | 2000-03-09 | Coloplast A/S | Composition susceptible d'absorber un fluide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3036033A1 (de) * | 1980-09-24 | 1982-05-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
GB8415188D0 (en) * | 1984-06-14 | 1984-07-18 | Geistlich Soehne Ag | Absorbent polymer material |
WO1993006802A1 (fr) * | 1991-10-09 | 1993-04-15 | David Rolf | Pansement a gel aqueux pour plaie et conditionnement |
US6635272B2 (en) * | 2000-11-09 | 2003-10-21 | Richard N. Leaderman | Wound dressing and drug delivery system |
-
2002
- 2002-01-22 GB GB0201385A patent/GB2384187A/en not_active Withdrawn
-
2003
- 2003-01-21 WO PCT/GB2003/000197 patent/WO2003061538A1/fr not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391799A (en) * | 1980-02-15 | 1983-07-05 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for treating white phosphorus burn wounds |
US4393048A (en) * | 1980-02-15 | 1983-07-12 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for wounds |
US5902600A (en) * | 1992-12-21 | 1999-05-11 | Healthpoint, Ltd. | Hydrogel polymer wound dressing |
WO2000012144A1 (fr) * | 1998-08-31 | 2000-03-09 | Coloplast A/S | Composition susceptible d'absorber un fluide |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696400B2 (en) | 2002-12-31 | 2010-04-13 | Ossur Hf | Wound dressing |
US7910793B2 (en) | 2002-12-31 | 2011-03-22 | Ossur Hf | Wound dressing |
US8247635B2 (en) | 2002-12-31 | 2012-08-21 | Ossur Hf | Wound dressing |
US7745682B2 (en) | 2003-09-17 | 2010-06-29 | Ossur Hf | Wound dressing and method for manufacturing the same |
US8093445B2 (en) | 2003-09-17 | 2012-01-10 | Ossur Hf | Wound dressing and method for manufacturing the same |
US7939578B2 (en) | 2007-02-23 | 2011-05-10 | 3M Innovative Properties Company | Polymeric fibers and methods of making |
CN102218154A (zh) * | 2010-04-15 | 2011-10-19 | 郑明义 | 羧甲基羟乙基改性棉纤维止血织物及其制备方法 |
US9970303B2 (en) | 2014-05-13 | 2018-05-15 | Entrotech, Inc. | Erosion protection sleeve |
CN105457080A (zh) * | 2015-12-09 | 2016-04-06 | 安徽宇宁生物科技有限公司 | 一种果胶创可贴 |
CN109833512A (zh) * | 2017-11-29 | 2019-06-04 | 江苏尚铖医疗器械有限公司 | 一种多功能创可贴 |
CN115382007A (zh) * | 2022-09-14 | 2022-11-25 | 安徽农业大学 | 一种抗菌和抗生物膜水凝胶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
GB2384187A (en) | 2003-07-23 |
GB0201385D0 (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kurakula et al. | Alginate-based hydrogel systems for drug releasing in wound healing | |
EP1341561B1 (fr) | Pansement pour traitement de plaies suintantes | |
EP1429702B1 (fr) | Pansements therapeutiques avec agrandissement d'ouvertures en fonction de l'exsudat | |
US6635272B2 (en) | Wound dressing and drug delivery system | |
EP0356060B1 (fr) | Composition pour remplir des blessures | |
EP2340053B1 (fr) | Dispositif de soins des plaies | |
CA2042609C (fr) | Gels utilises pour les blessures et methode d'utilisation | |
US6458380B1 (en) | Dressing and preparation delivery system | |
EP0568368B1 (fr) | Pansement lyophilisé | |
GB2377939A (en) | Apertured-sheet material | |
RU2715718C2 (ru) | Раневая повязка | |
US20070020318A1 (en) | Hydrocolloid materials for use in wound healing | |
JP6290184B2 (ja) | 創傷ドレッシング | |
EP1601388B1 (fr) | Materiaux hydrocolloides destines a etre utilises dans la cicatrisation des blessures | |
WO2003061538A1 (fr) | Pansements particulaires | |
GB2379392A (en) | Wound dressing sheet materials | |
WO2002009782A1 (fr) | Pansements non adherents pour blessures renfermant des cyclodextrines | |
EP0666081B1 (fr) | Pansement | |
Turner | Interactive dressings used in the management of human soft tissue injuries and their potential in veterinary practice | |
Hollis | Wound management products;‘advanced’dressings | |
Williams | Alginate cavity dressings for the diabetic foot | |
JPH04108454A (ja) | 抗菌剤含有創傷被覆材およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |